Literature DB >> 8577970

Quality control for SPECT systems.

L S Graham1.   

Abstract

A comprehensive set of acceptance tests is the basis for an effective quality control program. Acceptance tests indicate whether the scintillation camera meets published specifications but should also include evaluation of certain parameters not specified by the vendor but that can seriously affect image quality. Once a camera is "accepted," initial quality control tests serve as a benchmark for future measurements. Tomographic systems must be subjected to the same basic quality control program as planar cameras. Flood field images must be acquired and evaluated daily; spatial resolution must be tested once each week. Less frequently, parameters such as multiple-window spatial registration, collimator uniformity, system sensitivity, and camera "dead time" should be evaluated. Single photon emission computed tomographic systems require additional tests to ensure optimum performance. Center-of-rotation calibration and verification of detector registration are needed to avoid losses of spatial resolution. Flood corrections based on high-count images eliminate residual detector nonuniformiaties and correct for subtle collimator defects. Pixel size must be calibrated to avoid errors in attenuation correction and distortion when cardiac and brain reorientation software is used. Completed clinical studies must be checked for unacceptable patient movement and incomplete views. A quality control program may be time-consuming, but, from the standpoint of maximum benefit to patients and confidence in clinical interpretations, there is no alternative.

Entities:  

Mesh:

Year:  1995        PMID: 8577970     DOI: 10.1148/radiographics.15.6.8577970

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  1 in total

1.  Calculating Gamma Camera Uniformity Parameters: Beyond the Vendor-specific Protocol.

Authors:  Anil Kumar Pandey; Param Dev Sharma; Jay Prakash Kumar; Kartik Saroha; Chetan Patel; Chandra Sekhar Bal; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2017 Oct-Dec
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.